Report overview
Cell therapy is the emerging therapy involving transplantation of cellular material by injecting or grafting into the patient?s body to restore the function of the particular tissue or organ. Various instruments are used to carry out cell therapy to cure diabetes, some cancer types, neurological disorders, and related injuries.
This report contains market size and forecasts of Cell Therapy Instrument in global, including the following market information:
Global Cell Therapy Instrument Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Cell Therapy Instrument Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Cell Therapy Instrument companies in 2021 (%)
The global Cell Therapy Instrument market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Human Cells Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Cell Therapy Instrument include BD Bioscience, Danaher (Beckman Coulter, Inc.), General Electric, Lonza, Merck Kgaa, Miltenyi Biotec, Sartorius AG, Stemcell Technologies Inc. and Terumo Corporation and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Cell Therapy Instrument manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cell Therapy Instrument Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Cell Therapy Instrument Market Segment Percentages, by Type, 2021 (%)
Human Cells
Animal Cells
Global Cell Therapy Instrument Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Cell Therapy Instrument Market Segment Percentages, by Application, 2021 (%)
Cell Processing
Cell Preservation Distribution & Handling
Process Monitoring & Quality Control
Global Cell Therapy Instrument Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Cell Therapy Instrument Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cell Therapy Instrument revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Cell Therapy Instrument revenues share in global market, 2021 (%)
Key companies Cell Therapy Instrument sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Cell Therapy Instrument sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
BD Bioscience
Danaher (Beckman Coulter, Inc.)
General Electric
Lonza
Merck Kgaa
Miltenyi Biotec
Sartorius AG
Stemcell Technologies Inc.
Terumo Corporation
Thermo Fisher Scientific Inc.
